Valuation : Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 923K 871K 794K 1.48M 103M 1.5M 10.38M 3.99M 52.06M 4.03M 3.94M 165M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 711K 671K 611K 1.14M 79.03M 1.15M 7.99M 3.07M 40.09M 3.1M 3.04M 127M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 week-85.73%
Current month-85.73%
1 month-85.73%
3 months-85.71%
6 months-80.00%
Current year-66.67%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.03
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 25/06/2019
Director TitleAgeSince
Director/Board Member 64 31/12/2002
Director/Board Member 84 31/12/2004
Director/Board Member - 28/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-85.73%-.--%-99.61% 26.4K
+0.56%-0.79%-1.05%+46.70% 3,657B
+0.55%-3.61%+2.23%+964.14% 399B
-0.51%+4.26%+59.55%+117.91% 79.61B
+0.73%-2.09%-19.20%+17.82% 78.47B
+0.34%+0.55%-9.61%-14.25% 76.11B
+0.02%-3.16%-44.76%+183.87% 65.96B
-1.44%-6.45%+0.36%-17.14% 45.46B
+0.68%+1.96%-11.22%+50.56% 40.57B
-0.59%-0.56%+125.89%+247.29% 35.5B
Average +0.06%-3.92%+10.22%+149.73% 447.69B
Weighted average by Cap. +0.53%-3.98%+0.14%+131.10%

Financials

2015 2016
Net sales 4.22M 3.63M 3.43M 3.12M 5.83M 404M 5.89M 40.8M 15.7M 205M 15.85M 15.51M 650M 3.04M 2.62M 2.47M 2.25M 4.21M 291M 4.25M 29.43M 11.33M 148M 11.43M 11.18M 469M
Net income 151K 130K 123K 112K 209K 14.44M 211K 1.46M 562K 7.32M 567K 555K 23.26M -344K -296K -279K -254K -475K -32.89M -480K -3.32M -1.28M -16.68M -1.29M -1.26M -52.99M
Net Debt -340K -292K -276K -251K -470K -32.51M -474K -3.29M -1.26M -16.49M -1.28M -1.25M -52.37M -247K -212K -200K -183K -341K -23.62M -344K -2.39M -919K -11.98M -928K -907K -38.05M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
  1. Stock Market
  2. Stocks
  3. NMXS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!